Page 2,010«..1020..2,0092,0102,0112,012..2,0202,030..»

Broach Foundation Commits $5 Million to Brain Cancer Research

Posted: September 12, 2014 at 10:52 pm

Contact Information

Available for logged-in reporters only

Newswise The Broach Foundation for Brain Cancer Research has made a $5 million commitment to support glioblastoma multiforme research at The University of Texas MD Anderson Cancer Center. In recognition, the institution has named two patient pods at the Brain and Spine Center. The first one is named in memory of the late James Broach and the other is in honor of the foundation he and his wife, Jamie, established in 2011, months after he was diagnosed with the most aggressive form of brain cancer.

Theres no known cure for glioblastoma, and the low survival rate hasnt improved in years, due in part to inadequate funds for clinical research. In hopes of changing the statistics, the Broach Foundation directed its inaugural grant in 2012 toward research led by Jamess physician, Frederick Lang, M.D., professor and director of clinical research in Neurosurgery. Dr. Langs lab focuses on a viral smart bomb developed at MD Anderson by Juan Fueyo, M.D., professor in Neuro-Oncology - Research, called Delta-24-RGD, a type of cold virus thats engineered to infect and kill tumor cells. Lang pioneered the use of mesenchymal stem cells to deliver this virus and other biological therapies to brain tumors. Though James died at age 38 in 2013, the foundation continues to raise funds to support Lang and other collaborators at MD Anderson.

Philanthropy drives innovative research, which in turn drives the whole process of discovering new treatments and delivering them to the patient, said Lang. Thanks to the Broach Foundations generous support, we have promising clinical trials underway that mean hope for patients and their friends and loved ones coping with the effects of this deadly disease.

Fighting cancer with laughter Laughter and a positive outlook have been powerful weapons for the Broach family in their fight against a disease that is in no way funny. The couple chose to fight cancer with a combination of hard work and humor. They planned a comedy theme for their first gala fundraiser in May 2012 and called it Stand-Up for Brain Cancer. Actor, comedian and former Saturday Night Live cast member Kevin Nealon entertained a sold-out crowd at the River Oaks Country Club. Comedian Dennis Miller headlined the sold-out May 2013 event, followed by fellow Saturday Night Live alum Dana Carvey last April. Through gala proceeds, the Broach Foundation has contributed $1.7 million toward its $5 million commitment.

Were grateful to everyone who has contributed so generously to our foundation. The more we spread the news about the cutting-edge research taking place at MD Anderson and how brain cancer research continues to be underfunded, the more excited people become about wanting to join the cause, said Jamie.

NOTE TO MEDIA: Foundation representatives will view recognition plaques and attend a reception, 5-7 p.m. Sept. 15, 1515 Holcombe Blvd, R11 (access via elevator B), Rooms 2-3. Parking for media in Texas Medical Center Garage 10 will be validated.

Read this article:
Broach Foundation Commits $5 Million to Brain Cancer Research

Posted in Texas Stem Cells | Comments Off on Broach Foundation Commits $5 Million to Brain Cancer Research

Capitol Pain Institute Celebrating Three Employee Anniversaries and the Addition of Ten Medical Assistants

Posted: September 12, 2014 at 10:49 pm

Austin, TX (PRWEB) September 12, 2014

Representatives with Capitol Pain Institute announced today that Dr. Raimy Amasha and Dr. Anjuli Desai have completed their first year at Capitol Pain Institute while Jasmine Nelson, FNP has reached three years of service.

Dr. Matthew Schocket, founder of Capitol Pain Institute, went on to note that the medical institute also has 10 medical students or doctors who started their careers as medical assistants at Capitol Pain Institute.

Dr. Amasha is a Board Certified Anesthesiologist who completed his Anesthesiology residency at the University of Michigan and his Pain Management fellowship at The Johns Hopkins Hospital in Maryland.

His academic background is hallmarked by undergraduate training at Duke University in North Carolina, medical training at Vanderbilt University in Tennessee, and a focused research year studying stem cell biology at Stanford University in California.

As for Dr. Anjuli Desai: She is board certified in Physical Medicine & Rehabilitation and completed her fellowship training in Interventional Pain Medicine.

Areas of expertise include the treatment of back and neck pain, headaches, musculoskeletal and joint disorders, neuromodulation, including spinal cord stimulation, and acute pain management. She also performs a variety of outpatient pain management procedures including fluoroscopic-guided spine injections, nerve blocks and spinal cord stimulator trials.

The anniversaries and additions of 10 medical assistants are significant, according to Dr. Schocket, due to the fact that his staff was the first to bring stem cells therapy to Austin to relieve chronic pain.

Dr. Schocket, according to company representatives, is a recognized world-leader in the field of Pain Management.

He has lectured at multiple national and international conferences, including the American Society of Interventional Pain Physicians, the American Academy of Pain Management, the International Spine Injection Society, the Israeli Pain Society, and the International Neuromodulation Society.

View post:
Capitol Pain Institute Celebrating Three Employee Anniversaries and the Addition of Ten Medical Assistants

Posted in Maryland Stem Cells | Comments Off on Capitol Pain Institute Celebrating Three Employee Anniversaries and the Addition of Ten Medical Assistants

Knee arthritis one year after bone marrow stem cells by Harry Adelson, N.D. – Video

Posted: September 12, 2014 at 6:43 pm


Knee arthritis one year after bone marrow stem cells by Harry Adelson, N.D.
Christine discusses her results of her stem cell injection by Dr Harry Adelson for her arthritic knees http://www.docereclinics.com.

By: Harry Adelson, N.D.

Link:
Knee arthritis one year after bone marrow stem cells by Harry Adelson, N.D. - Video

Posted in Stem Cell Videos | Comments Off on Knee arthritis one year after bone marrow stem cells by Harry Adelson, N.D. – Video

Adult Stem Cell Research | Ray Flynn – Video

Posted: September 12, 2014 at 6:43 pm


Adult Stem Cell Research | Ray Flynn
Former Boston mayor Ray Flynn speaks about Catholic teaching on Adult Stem Cell Research, and his own advocacy on the issue.

By: The CatholicTV Network

Read more:
Adult Stem Cell Research | Ray Flynn - Video

Posted in Stem Cell Research | Comments Off on Adult Stem Cell Research | Ray Flynn – Video

Stem cell therapy | Stem cell treatment and medicine …

Posted: September 12, 2014 at 7:44 am

Prof. Alexander Smikodub

MD Ph.D

Alexander Smikodub jr.

MD Ph.D

Our clinic offers the advanced and patented methods of fetal stem cell treatment for various conditions and diseases. This method of treatment can be found in wikipedia: Stem cell therapy. Fetal stem cells are non-specialized cells that differentiate (turn) into any other cell type of the body that form organs and tissues. Fetal stem cells that we use for treatment have huge potential for growth, differentiation and are not rejected by the patients body, which allows to achieve unique long-term clinical effects.

We have more than 15 years of experience in stem cell therapy and are the leaders of the industry. Most of the methodic used in the clinic are unique and patent protected in many countries including USA. Since 1994 prof. Alexander Smikodub Sr. was the main researcher, doctor and administrator of the clinic. Now his son, Alexander Smikodub Jr. M.D. continues his fathers venture. During these years more than 6500 patients from all over the world received fetal stem cell treatment, resulting in significant improvement of their conditions, and in case of timely contact with us in complete cure of the diseases still considered lethal by most medical institutions.

Read more...

Stem cells are the new word in the medical science, possibly the new revolution. Their importance can be compared with antibiotics discovery or the first successful heart transplantation. They are the inner restorative and regenerative reserve of your body, found in blood, fat layer and bone marrow. After injection of a big stem cells doze, impaired tissues are recovered, regeneration speed is increased and overall condition is greatly improved. We use only material from healthy patients, which passes multiple security checks. They are a perfect material for treating a wide variety of neural and physical diseases.

View post:
Stem cell therapy | Stem cell treatment and medicine ...

Posted in Cell Medicine | Comments Off on Stem cell therapy | Stem cell treatment and medicine …

Dr. Jeff Christiansen is Now Offering Stem Cell Therapy for Pets at Five Brevard County Animal Hospitals and Beyond

Posted: September 12, 2014 at 7:44 am

Melbourne, Florida (PRWEB) September 11, 2014

Central Florida board-certified veterinary surgeon, Jeffrey S. Christiansen is proud to announce his partnerships with several Brevard County animal hospitals to bring regenerative veterinary medicine to pets. Dr. Christiansen has been working in the area since January 2006, credentialed to do stem cell therapy on small animals since 2008, and is happy to now offer his expertise through five different locations.

Over the years Dr. Christiansen has used stem cell therapy with Vet-Stem, Inc. on cruciate ligament and meniscus injuries, as well as osteoarthritis of the hips and other joints. Once Dr. Christiansen has identified a patient as a good stem cell therapy candidate, the pet undergoes a simple surgery to collect fat that is sent overnight to Vet-Stems lab in California. The day after the collection the fat is processed so stem cells can be extracted and put into concentrated, injectable doses. These doses are shipped back overnight to Dr. Christiansen and he is able to place them in the affected areas of the patient to encourage healing and regeneration.

Even if a pet is not an immediate candidate for stem cell therapy, but is undergoing an orthopedic or other type of surgery with Dr. Christiansen, he offers the ability to collect a small sample of fat for future stem cell use with Vet-Stem. Vet-Stem has the ability to cryo-bank stem cells and grow them in the future to provide doses when needed. This service is called StemInsure for dogs, and provides the insurance of a pet having a lifetime of stem cell therapy available from a single sample collection.

Stem cell therapy can be an alternative for pets that are unable to take anti-inflammatories or have digestive issues, as well as pets that are looking at long-term pain management. Because the stem cells come directly from the patient risk is low, and the procedure is natural.

As part of Superior Veterinary Surgical (and less-invasive) Solutions, Dr. Christiansen will be offering stem cell therapy at the following clinics beginning in September: Island Animal Hospital in Merritt Island, Brevard Animal Emergency Hospital in Malabar, Aloha Pet and Bird Hospital in Indian Harbour, Maybeck Animal Hospital in West Melbourne, and the Animal Emergency and Referral Center in Fort Pierce. He is bringing nearly 20 years of veterinary medicine experience with him, and takes pride in specializing in soft tissue, orthopedic, and spinal surgery.

About Dr. Christiansen and Superior Veterinary Surgical Solutions Jeffrey S. Christiansen, DVM, DACVS graduated from the University of Tennessee College of Veterinary Medicine in 1996. He completed his surgical residency in 2001, following an internship, and in 2002 he became a Diplomate of the American College of Veterinary Surgeons. Dr. Christiansen has been practicing in Brevard County since the beginning of 2006 and runs Superior Veterinary Surgical Solutions. In addition to stem cell therapy, some special areas of interest to Dr. Christiansen include artificial urethral sphincter (for incontinence), juvenile pubic symphysiodesis (for prevention of arthritis secondary to hip dysplasia), prophylactic gastropexy (for prevention of gastric dilatation-volvulus, commonly referred to as bloat), subcutaneous ureteral bypass (for obstructions between the kidney and bladder in cats), ureteral stenting (for obstruction between the kidney and bladder in dogs), and urethral stenting (for urethral obstruction), tibial tuberosity advancement (for tears of the cranial cruciate ligament; ACL in people) and tracheal stenting (for tracheal collapse).

About Vet-Stem, Inc. Since its formation in 2002, Vet-Stem, Inc. has endeavored to improve the lives of animals through regenerative medicine. As the first company in the United States to provide an adipose-derived stem cell service to veterinarians for their patients, Vet-Stem pioneered the use of regenerative stem cells for horses, dogs, cats, and some exotics. In 2004 the first horse was treated with Vet-Stem Regenerative Cell Therapy for a tendon injury that would normally have been career ending. Ten years later Vet-Stem celebrated its 10,000th animal treated, and the success of establishing stem cell therapy as a regenerative medicine for certain inflammatory, degenerative, and arthritic diseases. As animal advocates, veterinarians, veterinary technicians, and cell biologists, the team at Vet-Stem tasks themselves with the responsibility of discovering, refining, and bringing to market innovative medical therapies that utilize the bodys own healing and regenerative cells. For more information about Vet-Stem and Regenerative Veterinary Medicine visit http://www.vet-stem.com or call 858-748-2004.

Read more from the original source:
Dr. Jeff Christiansen is Now Offering Stem Cell Therapy for Pets at Five Brevard County Animal Hospitals and Beyond

Posted in Cell Therapy, Stem Cell Therapy | Comments Off on Dr. Jeff Christiansen is Now Offering Stem Cell Therapy for Pets at Five Brevard County Animal Hospitals and Beyond

Stem Cell Institute Public Seminar on Adult Stem Cell Therapy Clinical Trials in San Antonio, Texas September 20th, 2014

Posted: September 12, 2014 at 7:44 am

San Antonio, TX (PRWEB) September 11, 2014

The Stem Cell Institute, located in Panama City, Panama, will present an informational seminar about umbilical cord stem cell therapy on Saturday, September 20, 2014 in San Antonio, Texas at the La Cantera Hill Country Resort from 1:00 pm to 4:00 pm.

Stem Cell Institute Speakers include:

Neil Riordan PhD Umbilical Cord Stem Cell Clinical Trials for MS and Autism: Rationale and Clinical Protocols

Dr. Riordan is the founder of the Stem Cell Institute and Medistem Panama Inc.

Jorge Paz-Rodriguez MD Umbilical Cord Stem Cell Therapy for Arthritis, Inflammation and Sports Injuries

Dr. Paz is the Medical Director at the Stem Cell Institute. He practiced internal medicine in the United States for over a decade before joining the Stem Cell Institute in Panama.

Special Guest Speaker:

Janet Vaughan, DDS, MS, Professional Dancer- Successful Stem Cell Therapy in Panama: A Patients Perspective

Dr. Vaughan is Board Certified in Orthodontics (Diplomate of the American Board of Orthodontics) and she is a Fellow in the International College of Dentistry.

Follow this link:
Stem Cell Institute Public Seminar on Adult Stem Cell Therapy Clinical Trials in San Antonio, Texas September 20th, 2014

Posted in Stem Cell Therapy | Comments Off on Stem Cell Institute Public Seminar on Adult Stem Cell Therapy Clinical Trials in San Antonio, Texas September 20th, 2014

Feds give Cellerant $47.5M for stem cell treatment that preps for nuclear disaster

Posted: September 12, 2014 at 7:44 am

Stem cell therapy is one way thegovernments preparing for a nationimpacted by nuclear disaster.

Cellerant Therapeutics has received $47.5 million from the government to develop its treatment for radiation poisoning. If approved, the feds could buy the drug for the Strategic National Stockpile, which is a part of Project Bioshield- a portion of the Bush-era War on Terror that medically readies the nation against chemical, biological, radiological or nuclear attacks.

This is part of a $163.8 million commitment from theBiomedical Advanced Research and Development Authority, or BARDA.

The new dollars will go toward San Carlos, California-based Cellerants Phase 2 trial in patients with acute myeloid leukemia, as well as the preclinical trials to treat radiation poisoning, or Acute Radiation Syndrome.

As it relates toradiation poisoning, Cellerant said its drugCLT-008 is meant to provide hematopoietic support after exposure to ionizing radiation such as from a nuclear or radiological weapon, or from a nuclear accident, it said in a statement.

The privately held company also recently wrapped up early-stage clinical studies in patients with acute myeloid leukemia, as well as in patients that are undergoing an umbilical cord blood transplant. Cellerant found CLT-008, was safely tolerated in 75 patients, it said in a statement. Its Phase 2 is testing for a decrease in risk of febrile neutropenia, and infections stemming from chemo.

CLT-008 is essentially a collection of deep-freezed stem cells that can ultimately defrost and mature into working granulocytes, platelets and red blood cells in a person. In nonclinical models, Cellerant has shown that the treatments highly effective in providing protection from lethal radiation, preventing infection, facilitating stem cell engraftment and improving overall survival.

Get our daily newsletter or follow us.

Please enter your email below:

View original post here:
Feds give Cellerant $47.5M for stem cell treatment that preps for nuclear disaster

Posted in Cell Therapy | Comments Off on Feds give Cellerant $47.5M for stem cell treatment that preps for nuclear disaster

Cancer Survivor Saved by Measles Virus Raises Funds for Expanded Trial

Posted: September 12, 2014 at 3:59 am

Watch more news videos | Latest world newsCopy

After battling blood cancer for 10 years, Stacy Erholtz has no signs of the disease, thanks to an experimental treatment that used an engineered version of the measles virus.

Now, a year after finishing her treatment, the 50-year-old mother of three is transitioning from patient to advocate, working with the Rochester, Minnesota-based Mayo Clinic to expand the tiny trial that saved her life.

"When I was first diagnosed, there was not a lot of options. We strung together 10 years of life with a disease that is typically done in three to five," said Erholtz, who had tumors on her forehead, color bone, sternum and spine from multiple myeloma before the last-ditch treatment. "I'm encouraged. I want people to join me in remission right now."

Would You Volunteer to Get the Flu for $3,000?

Three Things You Should Know About Measles

Mom Whose Child Died After Contracting Chickenpox Advocates for Vaccines

Multiple myeloma is a type of blood cancer that affects the immune system, according to the Mayo Clinic. It can cause kidney-failure.htm" id="ramplink_kidney failure_" target="_blank">kidney failure, bone fractures and repeated infections.

After chemotherapy and stem cell transplants failed, Erholtz was accepted into the measles trial and given the highest possible dose of the engineered virus, which was designed to attack her cancer cells and leave her healthy cells alone, according to her physician, Dr. Stephen Russell.

"It's been adapted, so that it learned in the lab how to grow pretty efficiently on myeloma cells, "said Russell, who is in charge of the new trial. "It's lost the ability to cause harm on normal cells."

Original post:
Cancer Survivor Saved by Measles Virus Raises Funds for Expanded Trial

Posted in Minnesota Stem Cells | Comments Off on Cancer Survivor Saved by Measles Virus Raises Funds for Expanded Trial

Stem cells help researchers understand how schizophrenic brains function

Posted: September 12, 2014 at 3:57 am

PUBLIC RELEASE DATE:

11-Sep-2014

Contact: Mary Beth O'Leary moleary@cell.com 617-397-2802 Cell Press @CellPressNews

Using human induced pluripotent stem cells (hiPSCs), researchers have gained new insight into what may cause schizophrenia by revealing the altered patterns of neuronal signaling associated with this disease. They did so by exposing neurons derived from the hiPSCs of healthy individuals and of patients with schizophrenia to potassium chloride, which triggered these stem cells to release neurotransmitters, such as dopamine, that are crucial for brain function and are linked to various disorders. By discovering a simple method for stimulating hiPSCs to release neurotransmitters, the findings in the International Society for Stem Cell Research's journal Stem Cell Reports, published by Cell Press, could provide new insights into how neurons communicate with each other and could lead to a better understanding of the neural mechanisms underlying a range of brain disorders.

"This study is novel because it shows that stem cell neurons derived from patients can provide new insight into neurotransmitter mechanisms occurring in brain disorders such as schizophrenia," says senior study author Vivian Hook of the University of California, San Diego. "The approach of this study has broad opportunities for uncovering the neurochemistry of brain cell communication in numerous brain disorders, via these studies of human disease in a dish. Findings from these studies will lead to new therapeutic strategies for brain disorders, especially those mental and neurological diseases for which no drug treatments exist today."

hiPSCS are cells that are taken from adults, genetically reprogrammed to an embryonic stem cell-like state, and then converted into specialized cells such as neurons. Patient-derived hiPSCs offer the possibility of modeling an individual's disease in a dish and assessing which drugs will most effectively treat the disease. Because dysfunction in neural communication is linked to brain disorders such as schizophrenia, Hook and Fred Gage of The Salk Institute and Kristen Brennand of the Icahn School of Medicine at Mount Sinai set out to determine whether hiPSC-derived neurons can be induced to release important brain signaling chemicals, allowing disease mechanisms to be studied in a dish.

To address this question, the researchers exposed hiPSC-derived neurons from healthy individuals and patients with schizophrenia to a chemical known to stimulate the release of neurotransmitters. They found that these cells contained neurotransmitter-producing enzymes and were capable of secreting dopamine, norepinephrine, and epinephrineneurotransmitters that are crucial for brain function and that are linked to various disorders. Moreover, secretion of the three neurotransmitters was enhanced in hiPSC-derived neurons from schizophrenia patients compared with those from healthy individuals.

"The significance of this study is that patient-derived stem cell neurons can uncover previously unknown neurotransmitter brain mechanisms occurring in schizophrenia," Hook says. "Because in vivo human brain research is limited, hiPSC neurons derived from patients create new opportunities to understand changes occurring in brain cells occurring in nervous system disorders. These approaches can potentially define new drug targets for the development of therapeutic agents to improve the lives of schizophrenia patients."

###

Stem Cell Reports, Hook et al.: "Human iPSC Neurons Display Activity-Dependent Neurotransmitter Secretion: Aberrant Catecholamine Levels in Schizophrenia Neurons."

Read more:
Stem cells help researchers understand how schizophrenic brains function

Posted in California Stem Cells | Comments Off on Stem cells help researchers understand how schizophrenic brains function

Page 2,010«..1020..2,0092,0102,0112,012..2,0202,030..»